Phase I Study of JNJ-74699157 in Patients with Advanced Solid Tumors Harboring the KRAS G12C Mutation. Wang J, Martin-Romano P, Cassier P, Johnson M, et al. Oncologist 2022;27:536-e553.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wang J, Martin-Romano P, Cassier P, Johnson M, et al. Phase I Study of JNJ-74699157 in Patients with Advanced Solid Tumors Harboring the KRAS G12C Mutation. Oncologist 2022;27:536-e553.
PMID: 35325211